Effect of dexmedetomidine versus nalbuphine on the onset and duration of sensory and motor block: A randomized prospective single-blinded controlled study.
DOI:
https://doi.org/10.51168/7zs99744Keywords:
dexmedetomidine, nalbuphine, analgesia, brachial plexus block, motor blockadeAbstract
Background:
The present study was conducted to compare dexmedetomidine and nalbuphine as adjuvants to levobupivacaine in supraclavicular brachial plexus block with respect to onset and duration of sensory and motor block, duration of analgesia, and hemodynamic changes.
Methods:
A randomized, prospective, single-blinded controlled study was conducted among 110 patients aged 18–55 years belonging to ASA grade I and II undergoing upper limb surgeries under supraclavicular brachial plexus block. Patients were randomly allocated into two groups of 55 each. Group LD received levobupivacaine with dexmedetomidine, while Group LN received levobupivacaine with nalbuphine. Sensory block onset, motor block onset, duration of sensory and motor block, duration of analgesia, pulse rate, mean arterial pressure, and oxygen saturation were assessed.
Results:
The mean age of participants in Group LD and Group LN was 36.40±10.89 years and 39.18±12.05 years, respectively. Dexmedetomidine significantly reduced the onset time of sensory block (7.29±0.76 min vs 10.07±1.11 min; p<0.001) and motor block (13.09±0.84 min vs 16.27±0.98 min; p<0.001). Duration of sensory block (13.21±1.16 h vs 12.14±1.11 h; p<0.001), motor block (10.01±1.04 h vs 7.30±0.74 h; p<0.001), and analgesia (13.83±0.78 h vs 12.07±0.99 h; p<0.001) were significantly prolonged in Group LD. Pulse rate and mean arterial pressure were significantly lower in Group LD at 60 min, 2 h, and 6 h. Oxygen saturation remained stable and comparable between groups throughout the study.
Conclusion:
Both dexmedetomidine and nalbuphine serve as effective adjuncts to levobupivacaine for supraclavicular brachial plexus blockade. Dexmedetomidine provides enhanced efficacy through rapid onset and extended analgesia, whereas nalbuphine presents a cost-effective option with a commendable safety profile.
Recommendation:
Dexmedetomidine may be preferred as an adjuvant to levobupivacaine for supraclavicular brachial plexus block due to its faster onset and prolonged analgesic effect, while nalbuphine can be considered a cost-effective alternative.
References
1. Vidhya N, Shanmugapriya A, J SK, Akash B. Intrathecal Dexmedetomidine Versus Nalbuphine as Adjuvant to Levobupivacaine among Patients Undergoing Infraumblical Surgeries in a Tertiary Care Hospital. Journal of Chemical Health Risks. J Chem Heal Risks. 2024;14(6):1103-15.
2. Rajni Dhaka, S.P. Chittora GH. Comparative randomised double blind study to evaluate the efficacy of dexmedetomidine and nalbuphine used as an adjuvant with 0 . 5 % ropivacaine under epidural anaesthesia in patients of various infraumbilical surgeries. Int J Life Sci Biotechnol Pharma. 2025;14(2):765-9.
3. Badne AA, Tidke AP, Kendre DD, Jadhav BB. Postoperative Analgesia Of Additives Dexmedetomidine And Nalbuphine With Hyperbaric Ropivacaine For Infraumbilical And Lower Limb Surgeries. Afr J Biomed Res. 2024;27(3):1-6. https://doi.org/10.53555/AJBR.v27i3S.2303
4. Gupta P, Suthar A, Deganwa M, Goyal V, Devgan S. A Comparative Study of Dexmedetomidine versus Nalbuphine Used as an Adjuvant to Chloroprocaine for Daycare Surgeries Performed under Subarachnoid Block. Anesth Essays Res. 2022;16:336-9. https://doi.org/10.4103/aer.aer_85_22
5. Jyoti Mala, Sudha Singh, Pankaj Kumar AK. A Comparative Study of the Effect of Dexmedetomidine and Nalbuphine as an Adjuvant to Levobupivacaine in Ultrasound‑Guided Supraclavicular Brachial Plexus Block: A Prospective Randomized Double‑Blind Study. J Pharm Bioallied Sci. 2025;17:890-3. https://doi.org/10.4103/jpbs.jpbs_698_25
6. Khobragade SM, Kalbhor J, Saran R, Manjrekar S, Cham S. A comparative study of dexmedetomidine and nalbuphine as an adjuvant to bupivacaine in lower limb surgeries done under epidural anaesthesia. MedPulse Int J Anesthesiol. 2017;3(1):34-42. https://doi.org/10.26611/1015318
7. Lakshmi EA, Subhadra PJ. Comparison of the efficacy of epidural nalbuphine versus dexmedetomidine on the characteristics of spinal anaesthesia in patients undergoing lower limb orthopaedic surgeries : A prospective randomised, double ‑ blind, placebo-controlled study. J Clin Sci Res. 2020;9:82-8. https://doi.org/10.4103/JCSR.JCSR_30_19
8. Shukla U, Kumar M, Panchal D, Doneria D. A Comparative Study of Nalbuphine, Clonidine, and Dexmedetomidine as Adjuvants to Ropivacaine in Epidural Anesthesia for Lower Limb Surgery. Cureus. 2024;16(12):1-12. https://doi.org/10.7759/cureus.75507
9. Dwivedi N, Choudhuri P, Nayar P. Effects of Intravenous Dexmedetomidine on Sensory and Motor Block Characteristics in Adults Undergoing Infraumbilical Surgery Under Subarachnoid Block. Rev DA Soc Port Anestesiol. 2025;34:85-91.
10. Bupivacaine I, Oraby MA El, Hafez A, Moawad HE, Trabea GA, Salim MAA. Dexmedetomidine Versus Nalbuphine for Extremity Surgeries. Mansoura Med J. 2025;54:75-82.
11. Fawal SM El, Hamdy R, Kabarity E, Tarek N, Ahmed F, Abd SM, et al. Effect of Epidural Dexmedetomidine vs Nalbuphine for Labor Analgesia :# xd ; A randomized clinical trial: Effect of Epidural Dexmedetomidine vs Nalbuphine for Labor Analgesia : A. Egypt J Anaesth [Internet]. 2022;38(1):373-82. Available from: https://doi.org/10.1080/11101849.2022.2092300
12. Nagaraj B, Vinay BR, Vani N V. Intrathecal Nalbuphine and Dexmedetomidine as Adjuvants to Bupivacaine versus Plain Bupivacaine for Orthopedic Surgeries under Subarachnoid Block : A Comparative Study. Anesth Essays Res. 2022;16:381-5. https://doi.org/10.4103/aer.aer_12722
13. Kaur H, Singh A, Kumar S. Randomized Double-Blind Study : Evaluating Dexmedetomidine, Clonidine, and Nalbuphine as Adjuvants to Hyperbaric Ropivacaine 0 . 5 % in Bilateral Total Knee Replacement under Combined Spinal-Epidural Anesthesia. Int J Pharm Clin Res. 2024;16(2):1773-8.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Panchanana Sethi, Mrutyunjay Sahoo, Rojalin Sahoo, Ananta Narayan Patra, Dukhia Charan Kisku

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.














